C. elegans expressing D76N ß2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis. (2019)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-56498-5
PubMed Identifier: 31882874
Publication URI: http://europepmc.org/abstract/MED/31882874
Type: Journal Article/Review
Volume: 9
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322